Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Biomed ; 90(1-S): 32-35, 2019 01 25.
Article in English | MEDLINE | ID: mdl-30714996

ABSTRACT

Since the time of D. Morton in clinical evaluation we talked about the concept of hypermobility as a cause of diseases such as hallux valgus. To date, this concept has been deepened in order to better understand the pathological mechanisms that create deformity, in order to identify the most appropriate prevention and correction procedures. Physics introduced the concept of stiffness, a property that also belongs to the podalic structures. Changing the terminology is difficult, but the knowledge of biomechanics requires the elimination of the term hypermobility because it resultsinconsistent with the physics applied to the foot, in favor of the terms stiffness and compliance. These clarifications make it possible to us to deepen even more specific and timely therapeutic choices, thus reducing the risk of iatrogenic complications which follows interventions on the first ray.


Subject(s)
Hallux , Joint Instability/physiopathology , Metatarsophalangeal Joint , Humans , Joint Instability/complications
2.
Knee Surg Sports Traumatol Arthrosc ; 26(7): 2000-2010, 2018 Jul.
Article in English | MEDLINE | ID: mdl-28251260

ABSTRACT

PURPOSE: Although platelet-rich plasma (PRP) injection has shown controversial results for the treatment of Achilles tendinopathy, it remains the most used biological treatment. Recent findings seem to demonstrate that the stromal vascular fraction (SVF) within adipose tissue may counteract the impaired tendon homeostasis. The aim of this study was to prospectively compare the efficacy of PRP and SVF injection for the treatment of non-insertional Achilles tendinopathy. METHODS: Fourty-four patients were recruited in the study; 23 of them were assigned to the PRP group whereas 21 to the SVF group, treated unilaterally or bilaterally for a total of 28 tendons per group. All patients (age 18-55 years) were clinically assessed pre-operatively and at 15, 30, 60, 120 and 180 days from treatment, using the VAS pain scale, the VISA-A, the AOFAS Ankle-Hindfoot Score and the SF-36 form. The patients were also evaluated by ultrasound and magnetic resonance before treatment and after 4 (US only) and 6 months. RESULTS: Both treatments allowed for a significant improvement with respect to baseline. Comparing the two groups, VAS, AOFAS and VISA-A scored significantly better at 15 and 30 days in the SVF in comparison to PRP group (p < 0.05). At the following time points the scores were not significantly different between the two groups. No correlation has been found between clinical and radiological findings. CONCLUSIONS: Both PRP and SVF were safe, effective treatments for recalcitrant Achilles tendinopathy. The patients treated with SVF obtained faster results, thus suggesting that such a treatment should be taken into consideration for those patients who require an earlier return to daily activities or sport. LEVEL OF EVIDENCE: Randomized Controlled Clinical Trial, Level 1.


Subject(s)
Achilles Tendon , Adipose Tissue/cytology , Mesenchymal Stem Cell Transplantation/methods , Platelet-Rich Plasma , Tendinopathy/therapy , Adolescent , Adult , Female , Follow-Up Studies , Humans , Injections , Magnetic Resonance Imaging , Male , Middle Aged , Pain Measurement , Regeneration , Sports , Treatment Outcome , Ultrasonography , Young Adult
3.
BMC Complement Altern Med ; 16: 293, 2016 Aug 18.
Article in English | MEDLINE | ID: mdl-27538432

ABSTRACT

BACKGROUND: Current clinical procedures for rotator cuff tears need to be improved, as a high rate of failure is still observed. Therefore, new approaches have been attempted to stimulate self-regeneration, including biophysical stimulation modalities, such as low-frequency pulsed electromagnetic fields, which are alternative and non-invasive methods that seem to produce satisfying therapeutic effects. While little is known about their mechanism of action, it has been speculated that they may act on resident stem cells. Thus, the purpose of this study was to evaluate the effects of a pulsed electromagnetic field (PST®) on human tendon stem cells (hTSCs) in order to elucidate the possible mechanism of the observed therapeutic effects. METHODS: hTSCs from the rotator cuff were isolated from tendon biopsies and cultured in vitro. Then, cells were exposed to a 1-h PST® treatment and compared to control untreated cells in terms of cell morphology, proliferation, viability, migration, and stem cell marker expression. RESULTS: Exposure of hTSCs to PST® did not cause any significant changes in proliferation, viability, migration, and morphology. Instead, while stem cell marker expression significantly decreased in control cells during cell culturing, PST®-treated cells did not have a significant reduction of the same markers. CONCLUSIONS: While PST® did not have significant effects on hTSCs proliferation, the treatment had beneficial effects on stem cell marker expression, as treated cells maintained a higher expression of these markers during culturing. These results support the notion that PST® treatment may increase the patient stem cell regenerative potential.


Subject(s)
Magnetic Field Therapy , Stem Cells , Tendons/cytology , Cell Physiological Phenomena/radiation effects , Cells, Cultured , Humans , Stem Cells/cytology , Stem Cells/radiation effects
4.
Stem Cells Int ; 2016: 4373410, 2016.
Article in English | MEDLINE | ID: mdl-27057170

ABSTRACT

Increasing the success rate of rotator cuff healing remains tremendous challenge. Among many approaches, the possibility of activating resident stem cells in situ, without the need to isolate them from biopsies, could represent valuable therapeutic strategy. Along this line, it has been recently demonstrated that lipoaspirate product, Lipogems, contains and produces growth-factors that may activate resident stem cells. In this study, human tendon stem cells (hTSCs) from the rotator cuff were cocultured in a transwell system with the Lipogems lipoaspirate product and compared to control untreated cells in terms of cell proliferation, morphology, stem cell marker and VEGF expression, and differentiation and migration capabilities. Results showed that the Lipogems product significantly increases the proliferation rate of hTSCs without altering their stemness and differentiation capability. Moreover, treated cells increase the expression of VEGF, which is crucial for the neovascularization of the tissue during the healing process. Overall, this study supports that directly activating hTSCs with the Lipogems lipoaspirate could represent a new practical therapeutic approach. In fact, obtaining a lipoaspirate is easier, safer, and more cost-effective than harvesting cells from tendon or bone marrow biopsies, expanding them in GMP facility and then reinjecting them in the patient.

SELECTION OF CITATIONS
SEARCH DETAIL
...